LYZ and colonic neoplasm: Using colon cancer organoids carrying mutations in Apc, Kras, and Trp53 genes, we showed here that Dkk2 KO disrupted lysozyme (LYZ) positive cell formation in colon cancer organoids as well as metastatic nodules in vivo.